ACTA1 and colorectal carcinoma: Fluorescence immunostaining for the CAF marker αSMA and the M2 macrophage marker CD163 in 73 clinical CRC tumor samples allowed for quantification of αSMA-positive areas and abundance of CD163 positive cells in the tumor area (Figure 2a).